An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy (vol 11, e0155406, 2016)

被引：1
|
作者：
Llibre, Josep M.
Raffi, Francois
Moyle, Graeme
Behrens, Georg
Bouee, Stephane
Reilly, Geraldine
Borg, Peter
Piontkowsky, David
Rogatto, Felipe
机构：
来源：
PLOS ONE | 2016年 / 11卷 / 07期
关键词：
D O I：
10.1371/journal.pone.0159286
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：3
相关论文
共 23 条
  • [1] An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine plus Dolutegravir in Initial Therapy
    Llibre, Josep M.
    Raffi, Francois
    Moyle, Graeme
    Behrens, Georg
    Bouee, Stephane
    Reilly, Geraldine
    Borg, Peter
    Piontkowsky, David
    Rogatto, Felipe
    [J]. PLOS ONE, 2016, 11 (05):
  • [2] An indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir and dolutegravir plus abacavir/lamivudine
    Rogatto, Felipe
    Bouee, Stephane
    Jeanbat, Vivianne
    Piontkowsky, David
    Aragao, Filipa
    Bosse, Matthew
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 175 - 176
  • [3] SAFETY AND EFFICACY OF ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE IN TREATMENT-NAIVE JAPANESE PATIENTS WITH HIV-1 INFECTION
    Yajima, K.
    Yagura, H.
    Yukawa, S.
    Hirota, K.
    Ikuma, M.
    Kasai, D.
    Watanabe, D.
    Nishida, Y.
    Uehira, T.
    Shirasaka, T.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A237 - A237
  • [4] Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study
    Nathalie De Castro
    Alexandre Brun
    Pierre Sellier
    Gwenn Hamet
    Frédéric Mechaï
    Valérie Garrait
    Amélie Chabrol
    Marie-Anne Bouldouyre
    Eric Froguel
    Didier Troisvallets
    Pauline Caraux-Paz
    Constance Delaugerre
    Willy Rozenbaum
    Jean-Michel Molina
    [J]. AIDS Research and Therapy, 20
  • [5] Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study
    De Castro, Nathalie
    Brun, Alexandre
    Sellier, Pierre
    Hamet, Gwenn
    Mechai, Frederic
    Garrait, Valerie
    Chabrol, Amelie
    Bouldouyre, Marie-Anne
    Froguel, Eric
    Troisvallets, Didier
    Caraux-Paz, Pauline
    Delaugerre, Constance
    Rozenbaum, Willy
    Molina, Jean-Michel
    [J]. AIDS RESEARCH AND THERAPY, 2023, 20 (01)
  • [6] Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort
    Rotea-Salvo, Sandra
    Martinez-Pradeda, Alejandro
    Fernandez-Oliveira, Carla
    Gimenez-Arufe, Victor
    Balboa-Barreiro, Vanesa
    Margusino-Framinan, Luis
    Mena-De-Cea, Alvaro
    Vazquez-Rodriguez, Pilar
    Castro-Iglesias, Angeles
    Lopez-Calvo, Soledad
    Martin-Herranz, Isabel
    Miguez-Rey, Enrique
    Cid-Silva, Purificacion
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (04) : 221 - 226
  • [7] A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection: Analysis of Week 96 Results
    Zolopa, Andrew
    Sax, Paul E.
    DeJesus, Edwin
    Mills, Anthony
    Cohen, Calvin
    Wohl, David
    Gallant, Joel E.
    Liu, Hui C.
    Plummer, Andrew
    White, Kirsten L.
    Cheng, Andrew K.
    Rhee, Martin S.
    Szwarcberg, Javier
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (01) : 96 - 100
  • [8] Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study
    Baldin, G.
    Ciccullo, A.
    Capetti, A.
    Rusconi, S.
    Sterrantino, G.
    Cossu, M. V.
    Giacomelli, A.
    Lagi, F.
    Latini, A.
    Bagella, P.
    De Luca, A.
    Di Giambenedetto, S.
    Madeddu, G.
    [J]. HIV MEDICINE, 2019, 20 (02) : 164 - 168
  • [9] Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen
    Rizzardini, Giuliano
    Gori, Andrea
    Miralles, Celia
    Olalla, Julian
    Molina, Jean-Michel
    Raffi, Francois
    Kumar, Princy
    Antinori, Andrea
    Ramgopal, Moti
    Stellbrink, Hans-Jurgen
    Das, Moupali
    Chu, Hoa
    Ram, Renee
    Garner, Will
    Shao, Yongwu
    Chuck, Susan K.
    Piontkowsky, David
    Haubrich, Richard H.
    [J]. AIDS, 2019, 33 (10) : 1583 - 1593
  • [10] A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results
    Wohl, David
    Oka, Shinichi
    Clumeck, Nathan
    Clarke, Amanda
    Brinson, Cynthia
    Stephens, Jeffrey
    Tashima, Karen
    Arribas, Jose R.
    Rashbaum, Bruce
    Cheret, Antoine
    Brunetta, Jason
    Mussini, Cristina
    Tebas, Pablo
    Sax, Paul E.
    Cheng, Andrew
    Zhong, Lijie
    Callebaut, Christian
    Das, Moupali
    Fordyce, Marshall
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (01) : 58 - 64
123